Aclaris Therapeutics is a privately held specialty pharmaceutical company focused on the development of novel dermatological therapies.

AirXpanders is a medical device company that has developed the AeroForm tissue expander. AeroForm is a patient controlled breast tissue expander for reconstructive surgeries such as breast reconstruction after mastectomy.

Capnia is developing novel treatments for allergic rhinitis and migraine headache.

Carbylan Biosurgery is developing a next generation product combining hyaluronic acid and steroid for the treatment of osteoarthritis.

Ceptaris Therapeutics is a privately held specialty pharmaceutical company developing a product for the treatment of cutaneous T-cell lymphoma (CTCL).

Durata Therapeutics (NASDASQ: DRTX) is a pharmaceutical company focused on the development and commercialization of therapeutic solutions in infectious disease.

Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of Hepatitis. Our pipeline includes preclinical NCEs from discovery as well as repurposed clinical agents to treat Hepatitis C and Hepatitis D.

Essentialis is developing a novel therapy for the treatment of dyslipidemia.

MacroGenics, Inc. is developing antibodies and vaccines in the areas of oncology, inflammation, allergy, and infectious diseases.

MEI Pharma (NASDAQ: MEIP) is focused on the clinical development of novel therapies for cancer. MEI’s programs include a potential best-in-class HDAC inhibitor, Pracinostat, and isoflavone-based compounds ME-143 and ME-344.

Minerva Surgical is developing next-generation technology for treating excessive menstrual bleeding.

Nora Therapeutics is developing novel treatments in reproductive medicine.

OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

Palatin (NYSE: PTN) is developing melanocortin-based therapeutics. The company’s lead product, bremelanotide, is in Phase II clinical trials for female sexual dysfunction.

Rempex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to treat multi-drug resistant bacterial pathogens.

Revance Therapeutics is a specialty pharmaceutical company focused on discovering and developing therapeutic products in the areas of aesthetic medicine and therapeutic dermatology.

Sagent Pharmaceuticals is an international specialty injectable pharmaceutical company bringing finished pharmaceutical products to the U.S. market.

SentreHEART is a commercial stage medical device company with a novel suture delivery and tissue closure device for multiple clinical applications.

Synapse BioMedical is a medical device company developing neurostimulation products. The company’s products have been approved by the FDA for patients with spinal cord injury and amyotrophic lateral sclerosis.

TRIA Beauty is a leader in light-based therapeutic beauty systems that incorporate clinically-proven aesthetic technologies for at-home personal care regimens.